HIV/AIDS

  1. Knowledge and Impact of COVID-19 on Middle-Aged and Older People living with HIV in Lima, Peru

    1. Monica M. Diaz
    2. Diego M. Cabrera
    3. Marcela Gil-Zacarías
    4. Valeria Ramírez
    5. Manuel Saavedra
    6. Cesar Cárcamo
    7. Evelyn Hsieh
    8. Patricia J. García

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. The risks and benefits of providing HIV services during the COVID-19 pandemic

    1. John Stover
    2. Sherrie L. Kelly
    3. Edinah Mudimu
    4. Dylan Green
    5. Tyler Smith
    6. Isaac Taramusi
    7. Loveleen Bansi-Matharu
    8. Rowan Martin-Hughes
    9. Andrew N. Phillips
    10. Anna Bershteyn

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Non-nucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy is associated with lower cell-associated HIV RNA and DNA levels compared to protease inhibitor-based therapy

    1. Alexander O Pasternak
    2. Jelmer Vroom
    3. Neeltje A Kootstra
    4. Ferdinand WNM Wit
    5. Marijn de Bruin
    6. Davide De Francesco
    7. Margreet Bakker
    8. Caroline A Sabin
    9. Alan Winston
    10. Jan M Prins
    11. Peter Reiss
    12. Ben Berkhout
    13. The Co-morBidity in Relation to Aids (COBRA) Collaboration
    14. P Reiss
    15. FWNM Wit
    16. J Schouten
    17. KW Kooij
    18. RA van Zoest
    19. BC Elsenga
    20. FR Janssen
    21. M Heidenrijk
    22. W Zikkenheiner
    23. M van der Valk
    24. NA Kootstra
    25. T Booiman
    26. AM Harskamp-Holwerda
    27. I Maurer
    28. MM Mangas Ruiz
    29. AF Girigorie
    30. J Villaudy
    31. E Frankin
    32. AO Pasternak
    33. B Berkhout
    34. T van der Kuyl
    35. P Portegies
    36. BA Schmand
    37. GJ Geurtsen
    38. JA ter Stege
    39. M Klein Twennaar
    40. CBLM Majoie
    41. MWA Caan
    42. T Su
    43. K Weijer
    44. PHLT Bisschop
    45. A Kalsbeek
    46. M Wezel
    47. I Visser
    48. HG Ruhé
    49. C Franceschi
    50. P Garagnani
    51. C Pirazzini
    52. M Capri
    53. F Dall'Olio
    54. M Chiricolo
    55. S Salvioli
    56. J Hoeijmakers
    57. J Pothof
    58. M Prins
    59. M Martens
    60. S Moll
    61. J Berkel
    62. M Totté
    63. S Kovalev
    64. M Gisslén
    65. D Fuchs
    66. H Zetterberg
    67. A Winston
    68. J Underwood
    69. L McDonald
    70. M Stott
    71. K Legg
    72. A Lovell
    73. O Erlwein
    74. N Doyle
    75. C Kingsley
    76. DJ Sharp
    77. R Leech
    78. JH Cole
    79. S Zaheri
    80. MMJ Hillebregt
    81. YMC Ruijs
    82. DP Benschop
    83. D Burger
    84. M de Graaff-Teulen
    85. G Guaraldi
    86. A Bürkle
    87. T Sindlinger
    88. M Moreno-Villanueva
    89. A Keller
    90. C Sabin
    91. D de Francesco
    92. C Libert
    93. S Dewaele

    • Curated by eLife

      Evaluation Summary:

      This study addresses how antiviral treatment regimens impact persistence of an HIV reservoir in individuals who are treated for a long period. The authors examine measures of viral reservoir to understand how different antiviral treatment regimens impact residual virus in HIV infection. They find that NNRTI-based treatments are associated with lower viral reservoirs and better viral suppression than PI-based regimens, suggesting they may have some advantage at reducing HIV levels long term.

      (This preprint has been reviewed by eLife. We include the public reviews from the reviewers here; the authors also receive private feedback with suggested changes to the manuscript. Reviewer #1 agreed to share their name with the authors.)

    Reviewed by eLife

    4 evaluationsAppears in 1 listLatest version Latest activity
Previous Page 8 of 8